Combination chemotherapy with navelbine and continuous infusion of 5-fluorouracil in metastatic, chemotherapy refractory breast cancer
Open Access
- 1 August 2000
- journal article
- clinical trial
- Published by Elsevier
- Vol. 11 (8) , 1041-1044
- https://doi.org/10.1023/a:1008333327500
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Continuous Infusion Fluorouracil in the Management of Advanced Breast Cancer: A Phase II StudyTumori Journal, 2000
- A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devicesAnnals of Oncology, 1999
- The Addition of Paclitaxel to Continuous Infusion 5-Fluorouracil Is an Active Regimen for Metastatic Breast CancerAmerican Journal of Clinical Oncology, 1998
- Low-dose continuous intravenous infusion of 5-fluorouracil for metastatic breast cancerAnnals of Oncology, 1996
- Continuous infusional 5-fluorouracil in breast cancer or the revival of an old drug?Annals of Oncology, 1996
- Continuous 5-fluorouracil in the treatment of breast cancerBritish Journal of Cancer, 1994
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- Low-dose continuous infusion 5-fluorouracil. Evaluation in advanced breast carcinomaCancer, 1989
- Reporting results of cancer treatmentCancer, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958